Evidence map›Paper›PMID 34932310›Full record

ArticleACS chemical biology2022

Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems.

Elva Fridjonsdottir, Theodosia Vallianatou, Ioannis Mantas, Reza Shariatgorji, Anna Nilsson, Luke S Schembri, Luke R Odell, Per Svenningsson, Per E Andrén

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elva FridjonsdottirDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, SE-75124 Uppsala, Sweden.
Theodosia VallianatouDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, SE-75124 Uppsala, Sweden.ORCID 0000-0002-1477-7756
Ioannis MantasDepartment of Clinical Neuroscience, Section of Neurology, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Reza ShariatgorjiDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, SE-75124 Uppsala, Sweden.ORCID 0000-0001-9484-0921
Anna NilssonDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, SE-75124 Uppsala, Sweden.
Luke S SchembriDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.ORCID 0000-0001-5588-1077
Luke R OdellDepartment of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden.ORCID 0000-0001-7658-5103
Per SvenningssonDepartment of Clinical Neuroscience, Section of Neurology, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Per E AndrénDepartment of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, SE-75124 Uppsala, Sweden.ORCID 0000-0002-4062-7743
Uppsala University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regional brain distribution and metabolism of neurotransmitters and their response to drug treatment are fundamentally important for understanding the central effects of neuroactive substances. We used matrix-assisted laser desorption/ionization mass spectrometry imaging in combination with multivariate analysis to visualize in anatomical detail metabolic effects of aging and tacrine-mediated acetylcholinesterase inhibition on comprehensive neurotransmitter systems in multiple mouse brain regions of 12-week-old and 14-month-old mice. We detected age-related increases in 3,4-dihydroxyphenylacetaldehyde and histamine, indicating oxidative stress and aging deficits in astrocytes. Tacrine had a significant impact on the metabolism of neurotransmitters in both age groups; predominantly, there was an increased norepinephrine turnover throughout the brain and decreased 3-methoxy tyramine, a marker for dopamine release, in the striatum. The striatal levels of histamine were only elevated after tacrine administration in the older animals. Our results demonstrated that tacrine is a multitarget and region-specific neuroactive agent, inducing age-specific responses. Although well-studied, the complete mechanisms of the action of tacrine are not fully understood, and the current findings reveal features that may help explain its treatment-related effectiveness and central side effects.

Indexed as

Brain MappingAgingAnimalsBrainCholinesterase InhibitorsDopaminergic Neuronsgamma-Aminobutyric AcidLeast-Squares AnalysisMiceNeurotransmitter AgentsNorepinephrineSerotoninSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTacrineCholinesterase Inhibitorsgamma-Aminobutyric AcidNeurotransmitter AgentsNorepinephrineSerotoninTacrine

Identifiers

PMID34932310
PMCPMC8787750
OpenAlexW4200619732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.